Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 6 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9593082

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  2. US 9586908

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  3. US 9566283

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  4. US 9566278

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  5. US 9540334

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  6. US 9532998

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  7. US 9518040

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  8. US 9511058

    Methods for using carboxamide, sulfonamide and amine compounds

    Rigel Pharmaceuticals, Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  9. US 9499493

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  10. US 9481654

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  11. US 9475781

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  12. US 9453028

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  13. US 9439888

    Tetrazolones as a carboxylic acid bioisosteres

    Rigel Pharmaceuticals, Inc. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  14. US 9416112

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  15. US 9409884

    5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

    Rigel Pharmaceuticals, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  16. US 9353111

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  17. US 9353124

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  18. US 9353112

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  19. US 9353126

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  20. US 9346765

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  21. US 9321763

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  22. US 9283238

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  23. US 9266912

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  24. US 9266856

    AMPK—activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted